Atebimetinib

SKU: orb3028909

Description

Atebimetinib (IMM-1-104) is an orally active, deeply periodic MEK inhibitor that directly targets MEK and chronically suppresses MAPK signaling. It is intended for combination therapy in metastatic pancreatic cancer and non-small cell lung cancer (NSCLC).

Research Area

Signal Transduction

Key Properties

• CAS Number: 2669009-92-9
• MW: 506.55
• Purity: 99.40% (May vary between batches)
• Formula: C₂₃H₂₇FN₄O₆S
• SMILES: O=C1OC=2C=C(OC(=O)N(C)C)C=CC2C(=C1CC=3C=CC=C(NS(=O)(=O)NC)C3F)CN(C)C
• Target: MEK

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Quick Database Links

Gene Symbol

MEK